One liner: Cognitive Clarity Inc. is the producer of Percepta®, a patent-protected brain health dietary supplement (active ingredients, PTI-00703® and MemorTea®). This proposal outlines a strategic partnership between Cerebrum and Cognitive Clarity to further the development of brain health supplement products.

Cerebrum DAO Product Team

Peer Review Evaluation: Maryna Polyakova, Jimmie Gmaz, Peter Groenen Project Lead: Mark Melnykowycz Project Squad: Eleanor Davies, Brian Magierski

Project Team

CEO, Founder: Dr. Alan Snow

Summary Deal Analysis

This proposal seeks community approval for Cerebrum DAO to enter into a strategic partnership with Cognitive Clarity Inc. The proposed collaboration encompasses three main objectives:

1. Approve $30,000 in funding to replicate in vitro results in studies conducted by Cognitive Clarity.
2. Secure an upfront funding amount of $100,000 to acquire an ownership interest for Cerebrum of 10% of the IP portfolio of Cognitive Clarity, including all patents and pending patents and results of future research studies on such portfolio. The project IP will be secured in an IP-NFT to enable future fundraising into IP Token sale events to advance the IP to become an approved botanical drug in regulatory regimes such as the US FDA and/or the EU EMA. The $100,000 commitment will only be fulfilled if the replication study in item #1 above is successful.
3. Based on positive outcomes of the replication study results and upon completion of definitive documents for acquiring 10% interest in the Cognitive Clarity IP, Cerebrum will lead an IP Token (“IPT”) auction to raise additional funding for a human observational study of Percepta®, Cognitive Clarity’s natural cognitive enhancement supplement.
4. Upon a successful observational trial with human results, Cerebrum will proceed to integrate Percepta® into Cerebrum's product development roadmap, potentially influencing future innovations in brain health and offering discounted access to the Cerebrum community.

This partnership aims to advance our community’s understanding of mitigating early memory loss, using a safe and commercially available supplement, while providing our community with access to supplements and engagement in research opportunities. Through this partnership with Cognitive Clarity, Cerebrum is positioning itself at the forefront of neuroscience innovation and opening new avenues for growth and scientific exploration.

The community's vote will determine whether we proceed with this collaboration, which has the potential to significantly impact our DAO's future direction and contributions to the field of neuroscience.

About Percepta

Percepta® is a brain health dietary supplement produced by Cognitive Clarity Inc. It contains a concentrated blend of two key ingredients:

• PTI-00703®: A patent-protected extract from cat's claw (Uncaria tomentosa)
• MemorTea®: A specific Oolong tea extract, also patent protected

The product is designed to induce plaque and tangle inhibitory and reduce activity associated with normal age-related memory loss. Collectively, the product is protected by 34 patents and is based on 15 years of scientific research. The product is currently available over the counter as a dietary supplement. Percepta offers three products, Percepta®, Percepta Sport® and Percepta Professional®. Cerebrum DAO is interested in Percepta®. Of the three products, Cerebrum is interested in Percepta®, which is the most researched product and has the highest volume of published data.

...

Please visit the following link to view the full proposal, as the proposal content exceeds Discord Forum's character limit: https://docs.google.com/document/d/1PRF7wr_xo3J5-GGhyW-6mUmVBD9SEqn-otCOvxIImRM/edit?usp=sharing